We first examined whether CCR5 was modified by N-linked glycosylation, as the third extracellular loop of the protein contains a potential N-linked glycosylation site. Consistent with other reports (Rucker et al., 1996) , neither the N-glycosidase endo F nor tunicamycin treatment of Cf2Th-CD4/CCR5 cells resulted in a change in CCR5 mobility on SDS-PAGE (data not shown). By contrast, a shift in the mobility of CD4 was observed in the same tunicamycin-treated Cf2Th-CD4/CCR5 cells (data not shown).
Like most ␤-chemokine receptors, CCR5 also contains several extracellular regions rich in serines and threonines, which could be modified by O-linked glycosylation. In the case of CCR5, two such regions are 1 and 3) . The TLC plate was stained with ninhydrin to visualize amino acids (lanes 1 and 2), and an sulfate-treated cells ( Figure 3A) . We conclude that chloautoradiograph was made using the same TLC plate (lanes 3 and 4). rate does not interfere with the expression of CCR5 or with its conformation insofar as the latter can be assessed by the integrity of the 2D7 epitope. However, chlorate treatment does affect 5C7 binding, indicating Pouyani and Seed, 1995). We first analyzed chlorateand sulfate-treated cells by FACS with two CCR5 antithat in chlorate-treated cells, the CCR5 N terminus is specifically altered. 5C7 also failed to recognize a CCR5 bodies, 5C7 and 2D7, raised against human CCR5 expressed in murine cells (Wu et representing the amino acid residue at position 3, 10, and FFFY after extended exposure (data not shown). The efficiency of the sulfate incorporation into YFFF was significantly lower than wild-type CCR5 when compared with their cysteine-and methionine-labeled counterparts. Additionally, a construct expressing the last three tyrosines in the N terminus of CCR5 (FYYY) is sulfated far more efficiently than the sum of FYFF, FFYF, and FFFY ( Figures 5A and 5C ). These data imply that tyrosine 3 and at least one additional tyrosine in the CCR5 N terminus are sulfated, but that the presence of phenylalanines or the absence of proximal tyrosines retards the sulfation of constructs FYFF, FFYF, and FFFY. To examine the presence of sulfation in a different context, an additional panel of CCR5 mutants was made and tested for their ability to incorporate sulfate. A CCR5-derived construct (DDDD) in which each of the tyrosines was mutated to aspartic acid, and those in which three of four tyrosines were altered to aspartic acid (YDDD, DYDD, DDYD, and DDDY), were assayed. As shown in Figure 5B , the DDDD construct could not incorporate any detectable sulfate. Each of the constructs containing a single tyrosine could efficiently incorporate sulfate. The efficient sulfation of these constructs contrasts with the low levels of sulfation of the FYFF, FFYF, and FFFY variants. Together, these results suggest the possibility that the negative charges of the sulfate group itself contribute to the subsequent sulfation of nearby tyrosines.
Sulfated Tyrosines Contribute to the Efficiency of HIV-1 Entry
To determine a role for the CCR5 tyrosine sulfates in HIV-1 entry, we compared the ability to support HIV-1 infection of CCR5 variants shown to be sulfated ( Figure  5 ) with analogous variants in which the sulfated tyrosine was altered to phenylalanine. Figure 6A shows that vi- Figure 5A shows that wild-type CCR5 was restored to a tyrosine. Each of these restored tyrosines is modified by sulfate ( Figure 5B) Figures  6D and 6E ). These data demonstrate that the presence of sulfated tyrosines at positions 10, 14, and 15, and to a lesser extent at position 3, contributes substantially to CCR5's ability to support infection by two primary HIV-1 viruses.
To distinguish the role of the sulfate group from that of the phenyl ring of the sulfated tyrosine, we compared directly the coreceptor function of the DYDD, DDYD, and DDDY constructs with their unsulfated analogs (DFDD, DDFD, and DDDF, respectively). As summarized in Figures 6D and 6E, the efficiency with which viruses pseudotyped with the ADA and YU2 envelope glycoproteins infected cells expressing each construct lacking a sulfate group was substantially less than that of cells expressing CCR5 variants in which the sulfate was present. Specifically, the DFDD variant supported entry of YU2 and ADA viruses at 33% and 30%, respectively, of the infection levels supported by the DYDD construct. Similarly, the DDFD protein supported YU2 and ADA virus entry at 15% and 10%, respectively, of that observed for the DDYD variant, and the DDDF protein supported YU2 and ADA virus entry at 34% and 10%, respectively, of that observed for the DDDY construct. We conclude that the presence of a sulfate moiety on tyrosines 10, 14, and 15 of CCR5 substantially enhances the entry of at least two primary HIV-1 viruses. ., 1996; Farzan et al., 1997b) 
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